Stockscreener 앱 받기
15.05
6.89%
0.97
시간 외 거래:
15.20
0.15
+1.00%
전일 마감가:
$14.08
열려 있는:
$14.1
하루 거래량:
627.11K
Relative Volume:
1.36
시가총액:
$1.13B
수익:
$62.71M
순이익/손실:
$-112.51M
주가수익비율:
-9.9669
EPS:
-1.51
순현금흐름:
$-96.01M
1주 성능:
+1.62%
1개월 성능:
+20.02%
6개월 성능:
+14.19%
1년 성능:
+27.98%
1일 변동 폭
$14.06
$15.28
1주일 범위
$13.60
$15.28
52주 변동 폭
$9.03
$17.70
Zymeworks Inc. Stock (ZYME) Company Profile
명칭
Zymeworks Inc.
전화
604-678-1388
주소
1385 West 8th Avenue, Suite 540, Vancouver, BC
ZYME을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZYME
Zymeworks Inc.
|
15.05 | 1.07B | 62.71M | -112.51M | -96.01M | -1.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-20 | 개시 | TD Cowen | Buy |
| 2024-12-16 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-11-07 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-11-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-21 | 재개 | Wells Fargo | Overweight |
| 2023-01-04 | 재확인 | H.C. Wainwright | Neutral |
| 2022-12-20 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-10-21 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-10-04 | 재개 | Wells Fargo | Overweight |
| 2022-05-05 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-03-15 | 개시 | Evercore ISI | Outperform |
| 2021-12-10 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-17 | 재개 | Guggenheim | Neutral |
| 2021-10-07 | 개시 | Jefferies | Hold |
| 2021-03-31 | 개시 | Credit Suisse | Outperform |
| 2021-02-25 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-02-08 | 재개 | H.C. Wainwright | Buy |
| 2021-01-25 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-09-29 | 재개 | JP Morgan | Neutral |
| 2020-08-06 | 개시 | SVB Leerink | Outperform |
| 2020-01-10 | 개시 | Wolfe Research | Outperform |
| 2019-12-09 | 개시 | JP Morgan | Neutral |
| 2019-11-25 | 개시 | H.C. Wainwright | Buy |
| 2019-11-20 | 개시 | Guggenheim | Buy |
| 2019-09-30 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-08-30 | 개시 | Stifel | Buy |
| 2019-07-18 | 개시 | Deutsche Bank | Buy |
| 2018-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2018-03-19 | 개시 | Raymond James | Outperform |
모두보기
Zymeworks Inc. 주식(ZYME)의 최신 뉴스
Has Zymeworks Inc. found a price floorWeekly Gains Report & Capital Efficient Trade Techniques - Newser
What Fibonacci levels say about Zymeworks Inc. reboundTrade Analysis Report & Fast Gain Stock Trading Tips - Newser
Zymeworks Inc. $ZYME Shares Sold by Wellington Management Group LLP - MarketBeat
Real time breakdown of Zymeworks Inc. stock performanceWeekly Market Report & Long Hold Capital Preservation Tips - Newser
What candlestick patterns are forming on Zymeworks Inc.New Guidance & Expert Approved Momentum Trade Ideas - Newser
Risk adjusted return profile for Zymeworks Inc. analyzedWeekly Trading Summary & Long-Term Investment Growth Plans - Newser
Heatmap analysis for Zymeworks Inc. and competitorsWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - Newser
What’s the fair value of Zymeworks Inc. stock2025 Valuation Update & Real-Time Market Trend Scan - خودرو بانک
How to build a custom watchlist for Zymeworks Inc.Market Growth Review & Detailed Earnings Play Strategies - Newser
Nuveen LLC Makes New $2.37 Million Investment in Zymeworks Inc. $ZYME - MarketBeat
Zymeworks Inc. $ZYME Shares Sold by Vanguard Group Inc. - MarketBeat
Custom watchlist performance reports with Zymeworks Inc.Dollar Strength & High Return Trade Opportunity Guides - Newser
Zymeworks Inc. stock trend forecast2025 Breakouts & Breakdowns & Risk Controlled Stock Alerts - Newser
Zymeworks Inc. (NYSE:ZYME) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
What is Zymeworks Inc.’s TAM (Total Addressable Market)Market Risk Summary & Community Supported Trade Ideas - خودرو بانک
Sentiment analysis tools applied to Zymeworks Inc.Market Weekly Review & Daily Stock Trend Watchlist - Newser
Zymeworks (NASDAQ:ZYME) Shares Gap DownWhat's Next? - MarketBeat
Zymeworks (NYSE:ZYME) Shares Gap DownHere's Why - MarketBeat
Detecting price anomalies in Zymeworks Inc. with AI2025 Sector Review & Fast Moving Stock Watchlists - Newser
ADAR1 Capital Management LLC Invests $596,000 in Zymeworks Inc. $ZYME - MarketBeat
Redmile Group LLC Reduces Position in Zymeworks Inc. $ZYME - MarketBeat
Vestal Point Capital LP Boosts Holdings in Zymeworks Inc. $ZYME - MarketBeat
Real time pattern detection on Zymeworks Inc. stock2025 Market Sentiment & Reliable Intraday Trade Alerts - Newser
Earnings Update: What is the earnings history of Zymeworks Inc.Product Launch & Weekly Stock Breakout Alerts - خودرو بانک
What momentum shifts mean for Zymeworks Inc.Rate Cut & AI Optimized Trading Strategy Guides - Newser
Tema Etfs LLC Purchases Shares of 33,001 Zymeworks Inc. $ZYME - MarketBeat
Sector ETF performance correlation with Zymeworks Inc.Risk Management & Free Technical Confirmation Trade Alerts - Newser
Why Zymeworks Inc. stock attracts strong analyst attention2025 Growth vs Value & Long-Term Growth Plans - Newser
S P Trends: Is Zymeworks Inc. forming a breakout patternMarket Trend Report & Consistent Profit Alerts - خودرو بانک
Zymeworks Inc. $ZYME Shares Sold by Walleye Capital LLC - MarketBeat
Zymeworks Inc. $ZYME Shares Bought by AlphaQuest LLC - MarketBeat
Is Zymeworks Inc. forming a breakout patternQuarterly Risk Review & Stepwise Trade Execution Plans - خودرو بانک
Zymeworks’ Pipeline Resilience Amid ZW171 Setback: Strategic Reallocation and ADC Innovation Drive Long-Term Value - AInvest
Zymeworks: Despite T-Cell Engager Setback, ADC Candidates Press On (NASDAQ:ZYME) - Seeking Alpha
Zymeworks Pulls Plug On Early-Stage Cancer Potential As Therapy Unlikely To Provide Benefit - AOL.com
Clinical Focus: Zymeworks Discontinues Development of ZW171 in Phase 1 Trial - Targeted Oncology
Is Zymeworks Inc. stock a good pick for beginnersJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - خودرو بانک
What machine learning models say about Zymeworks Inc.2025 Fundamental Recap & Community Driven Trade Alerts - Newser
Zymeworks Inc. shares fall 3.31% intraday after discontinuing clinical development of ZW171. - AInvest
Zymeworks down after dropping anticancer agent (ZYME:NASDAQ) - Seeking Alpha
Zymeworks Inc. (ZYME) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):